Showing results (41-50 of 192) with videos related to
Sort By:
Pageof 20
Lung Cancer (Amsterdam, Netherlands)|June 25, 2020
Evaluation of a new diagnostic immunohistochemistry approach for ROS1 rearrangement in non-small cell lung cancerWenxian Wang, Guoping Cheng, Gu Zhang, et al.Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|October 14, 2019
High accuracy detection of malignant pleural effusion based on label-free surface-enhanced Raman spectroscopy and multivariate statistical analysisKaiyuan Liu, Shangzhong Jin, Zhengbo Song, et al.Journal of Cancer Research and Clinical Oncology|May 15, 2012
Cutaneous metastasis as a initial presentation in advanced non-small cell lung cancer and its poor survival prognosisZhengbo Song, Baochai Lin, Lan Shao, et al.Medical Oncology (Northwood, London, England)|December 1, 2010
Third-line therapy for advanced non-small-cell lung cancer patients: feasible drugs for feasible patientsZhengbo Song, Yongfeng Yu, Zhiwei Chen, et al.World Neurosurgery|February 26, 2013
Brain metastases from esophageal cancer: clinical review of 26 casesZhengbo Song, Baochai Lin, Lan Shao, et al.Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|September 20, 2012
[Advances of molecular subtype and targeted therapy of lung cancer]Lan Shao, Zhengbo Song, Yiping Zhang, et al.Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|September 20, 2012
[Retrospective study on lobe-specific lymph node dissection for patients with early-stage non-small cell lung cancer]Jian Chen, Feng Mao, Zhengbo Song, et al.Oncotargets and Therapy|April 4, 2017
Salvage treatment with apatinib for advanced non-small-cell lung cancerZhengbo Song, Xinmin Yu, Guangyuan Lou, et al.Clinical Lung Cancer|March 22, 2017
MET Gene Amplification and Overexpression in Chinese Non-Small-Cell Lung Cancer Patients Without EGFR MutationsZhengbo Song, Xuzhou Wang, Yuhui Zheng, et al.Neoplasma|November 18, 2024
Correction: Efficacy and safety analysis of anlotinib in combination with immune checkpoint inhibitors for second-line and subsequent extensive-stage small-cell lung cancerXixi Ying, Zheng Shi, Rongjun Shao, et al.Pageof 20